Breast pain or tenderness
dizziness or light-headedness
headache
rapid weight gain
swelling of feet and lower legs
vaginal bleeding
But lower doses can lead to higher pregnancy rates....so thats where weight comes into play...
Previously the Ortho patch was a one dose fits all...so same dose for 300lbs woman as a 125lb women. So Twirla offers a lower dose for women who want a lower dose option.
Recent AGRX News
- Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/28/2024 12:05:00 PM
- Agile Therapeutics Announces Delisting from Nasdaq • GlobeNewswire Inc. • 03/25/2024 08:30:00 PM
- Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024 • GlobeNewswire Inc. • 03/21/2024 10:35:00 AM
- Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024 • GlobeNewswire Inc. • 03/20/2024 12:15:00 PM
- Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution • GlobeNewswire Inc. • 03/13/2024 11:31:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/23/2024 09:57:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/23/2024 09:55:25 PM
- Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds • GlobeNewswire Inc. • 02/22/2024 02:01:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:30 PM
- Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update • GlobeNewswire Inc. • 02/15/2024 09:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:02:00 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/07/2024 09:51:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:14:35 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/05/2024 02:21:25 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/02/2024 09:27:13 PM
- The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost • GlobeNewswire Inc. • 01/23/2024 02:29:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/20/2023 01:00:42 PM
- Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement • GlobeNewswire Inc. • 12/12/2023 01:01:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/11/2023 10:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 01:00:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:15:21 PM
- Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/09/2023 01:05:00 PM
- Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023 • GlobeNewswire Inc. • 10/26/2023 12:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM